Joachim Senger

Learn More
An anemia management protocol ensures consistent treatment of anemia in end-stage renal disease (ESRD) patients by basing a treatment plan on the evaluation of hematocrit values and iron stores, the provision of safe and effective iron supplementation the systematic dosing of recombinant human erythropoietin (rHuEPO), and careful monitoring of patient'(More)
OBJECTIVE To investigate the hematologic and economic advantages of using iron dextran as the sole supplemental agent to safely increase and maintain hematocrit levels and iron availability while optimizing erythropoietin dosing in patients on chronic hemodialysis. DESIGN Iron dextran 100 mg (2 ml) was administered i.v. slow push, undiluted three times(More)
Iron deficiency is common in patients with end stage renal disease (ESRD) receiving recombinant human erythropoietin (rHuEPO). Consequently, such patients require routine iron monitoring by measurement of serum ferritin and transferrin saturation, with interpretation of these values in light of the response to rHuEPO. This article will review issues related(More)
This paper reports the SilverGame project objectives and activities for fostering the social inclusion and well-being of elderly persons. The technological advances of information and communication technologies for building an interactive platform are obious. Information and communication technologies can help avoiding social isolation of elderly persons.(More)
  • 1